Faculty

UCI neuroscientist Hans Keirstead

UCI behind world’s first embryonic stem cell study in humans

A therapy developed at UC Irvine that made paralyzed rats walk again will become the world’s first embryonic stem cell treatment tested in humans.

Professor Hongkai Zhao

Mathematics in the real world

Professor Hongkai Zhao uses mathematics to make computers run better, which in turn improves medical imaging and engineering design.

Mads Sulbaek Andersen

Termite insecticide a potent greenhouse gas

An insecticide used to fumigate termite-infested buildings is a strong greenhouse gas that lives in the atmosphere nearly 10 times longer than previously thought, UC Irvine research has found.

Steven Topik

Coffee: the drink that changed the world

With 400 million cups brewed each day, the United States has staked its claim as the top coffee-consuming nation.

‘Eaters’ eyes on the Capitol

UC Irvine community shares thoughts about the inauguration of Barack Obama.

UC Irvine students march in solidarity with Martin Luther King Jr.'s dream

Keeping King’s dream alive

Roundup of events for Martin Luther King Jr. birthday and following week

Dr. Steven Potkin

Brain imaging facilitates mental illness treatments

As a brain imaging researcher who studies schizophrenia, Dr. Steven Potkin saw a large problem limiting growth in his field and the potential for new clinical treatments.

Scientists use environmentally controlled clean rooms to manufacture a variety of products

Small-scale lab yields large possibilities

UC Irvine opens its second clean room suitable for producing microdevices with organic material.

Andrew Penner

Study shows ethnicity isn’t black and white

Losing your job or doing jail time can affect how people perceive your racial background, according to a recent study co-authored by Andrew Penner, UC Irvine sociology assistant professor.

Frank LaFerla

Institute for Brain Aging and Dementia gets new chief

Neurobiologist Frank LaFerla is taking the reins of the UC Irvine Institute for Brain Aging & Dementia, hoping to boost clinical offerings and move forward with a new building dedicated to Alzheimer’s disease research.